Quick Summary:
Emerging trends in the global active pharmaceutical ingredients market reveal that the market is poised for significant growth. The evolving manufacturing scenario in developing countries, the increasing number of type II drug master files, and the rising need to focus on core competencies are driving rapid advancements in this sector.
In the market segmentation, two main manufacturing types are leading the sector: captive and contract APIs. The market is driven by both innovative and generic APIs, highlighting the diversity of opportunities available. Geographically, the active pharmaceutical ingredients market spans across Asia, North America, Europe and the Rest of the World, ensuring a global reach and numerous market entry points.
This report is critical for those desiring a complete analysis of the active pharmaceutical ingredients market, forecasting future trends, industry challenges and offering a robust vendor analysis. The study is backed by extensive research, synthesizing information from key industry influencers and providing a dependable, comprehensive understanding of the market growth and its trajectory.
Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by evolving API manufacturing scenario in developing countries, the increasing number of type II drug master files (DFMS), and the growing need to focus on core competencies.
The active pharmaceutical ingredients market is segmented as below:
By Manufacturing Type
- Captive APIs
- Contract APIs
By Type
- Innovative APIs
- Generic APIs
By Geography
- Asia
- North America
- Europe
- Rest of World (ROW)
The report on the active pharmaceutical ingredients market covers the following areas:
- Active pharmaceutical ingredients market sizing
- Active pharmaceutical ingredients market forecast
- Active pharmaceutical ingredients market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
Executive Summary
The publisher recognizes the following companies as the key players in the global active pharmaceutical ingredients market: AbbVie Inc., Amneal Pharmaceuticals Inc., Apotex Inc., Aurobindo Pharma Ltd., Cadila Pharmaceuticals Ltd., Cambrex Corp., Cipla Ltd., Dr Reddys Laboratories Ltd., GlaxoSmithKline Plc, Indena S.p.A., INTERNATIONAL CHEMICAL INVESTORS S.E., Koninklijke DSM NV, Lupin Ltd., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Thermo Fisher Scientific Inc., and Viatris Inc.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is paradigm shift in API manufacturing.`
According to the report, one of the major drivers for this market is the evolving API manufacturing scenario in developing countries.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned
A selection of companies mentioned in this report includes:
- AbbVie Inc.
- Amneal Pharmaceuticals Inc.
- Apotex Inc.
- Aurobindo Pharma Ltd.
- Cadila Pharmaceuticals Ltd.
- Cambrex Corp.
- Cipla Ltd.
- Dr Reddys Laboratories Ltd.
- GlaxoSmithKline Plc
- Indena S.p.A.
- INTERNATIONAL CHEMICAL INVESTORS S.E.
- Koninklijke DSM NV
- Lupin Ltd.
- Novartis AG
- Pfizer Inc.
- Sanofi SA
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Thermo Fisher Scientific Inc.
- Viatris Inc.